Flagship explainer
What drives TriSalus Life Sciences, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$39.2M | FY2025 |
| |
| Income before tax | −$39.2M | FY2025 |
|
| Operating income | −$26.9M | FY2025 |
|
| $45.2M | FY2025 |
| |
| Ending assets | $35.3M | FY2025 |
|
| Beginning assets | $24M | FY2024 |
|
| −$33.9M | FY2025 |
| |
| −$25.9M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001628280-26-015163